HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via CrossRef Citing Articles via Google Scholar Google Scholar Articles by Lazdina, U. Articles by Sällberg, M. Search for Related Content PubMed PubMed Citation Articles by Lazdina, U. Articles by Sällberg, M. Agricola Articles by Lazdina, U. Articles by Sällberg, M.

Priming of cytotoxic T cell responses to exogenous hepatitis B virus core antigen is B cell dependent

¹ Division of Clinical Virology, F68, Karolinska Institutet at Huddinge University Hospital, S 141 86 Stockholm, Sweden
² Biomedical Research and Study Center, University of Latvia, Riga, Latvia
³ Department of Biochemistry, Commonwealth University, Richmond, VA, USA
⁴ Vaccine Research Institute of San Diego, San Diego, CA, USA

Correspondence
Matti Sällberg
Matti.Sallberg{at}impi.ki.se

The hepatitis B virus (HBV) core antigen (HBcAg) has a unique ability to bind a high frequency of naive human and murine B cells. The role of HBcAg-binding naive B cells in the immunogenicity of HBcAg is not clear. The HBcAg-binding properties of naive B cells were characterized using HBcAg particles with mutated spike region (residues 76–85) sequences. Deletion of residues 76–85 (HBc76–85) destroyed naive B cell binding, whereas deletion of residues 79–85 did not. HBcAg particles with an Ile instead of the natural Ala at position 80 did not bind naive B cells, whereas reversion of Ile⁸⁰Ala restored B cell binding. Destroying the B cell-binding ability of HBcAg had a marginal effect on the overall B cell immunogenicity of the different particles, suggesting that they were equally efficient in priming T helper cells. Therefore, the importance of HBcAg-binding B cells is studied with relation to the priming of HBcAg-specific cytotoxic T cells (CTLs). The role of HBcAg-binding B cells in the priming of HBcAg-specific CTLs was evaluated by immunization with endogenous HBcAg (DNA immunization) and exogenous recombinant HBcAg particles. Endogenous HBcAg primed HBcAg-specific CTLs in wild-type and B cell-deficient mice, whereas exogenous HBcAg primed HBcAg-specific CTLs only in wild-type mice. Importantly, HBc76–85 did not prime CTLs despite the presence of B cells. Thus, the ability of exogenous HBcAg particles to prime specific CTLs is B cell dependent, suggesting a possible role for HBcAg-binding B cells in HBV infections.

This article has been cited by other articles:

				B. O. Lee, A. Tucker, L. Frelin, M. Sallberg, J. Jones, C. Peters, J. Hughes, D. Whitacre, B. Darsow, D. L. Peterson, et al. Interaction of the Hepatitis B Core Antigen and the Innate Immune System J. Immunol., June 1, 2009; 182(11): 6670 - 6681. [Abstract] [Full Text] [PDF]

				S. A. Keller, C. E. von Allmen, H. J. Hinton, M. Bauer, S. Muntwiler, K. Dietmeier, P. Saudan, and M. F. Bachmann Follicular and Marginal Zone B Cells Fail to Cross-Present MHC Class I-Restricted Epitopes Derived from Viral Particles J. Immunol., May 15, 2009; 182(10): 6261 - 6266. [Abstract] [Full Text] [PDF]

				W. Yeo, T. C. Chan, N. W.Y. Leung, W. Y. Lam, F. K.F. Mo, M. T. Chu, H. L.Y. Chan, E. P. Hui, K. I.K. Lei, T. S.K. Mok, et al. Hepatitis B Virus Reactivation in Lymphoma Patients With Prior Resolved Hepatitis B Undergoing Anticancer Therapy With or Without Rituximab J. Clin. Oncol., February 1, 2009; 27(4): 605 - 611. [Abstract] [Full Text] [PDF]

				L. Frelin, T. Wahlstrom, A. E. Tucker, J. Jones, J. Hughes, B. O. Lee, J.-N. Billaud, C. Peters, D. Whitacre, D. Peterson, et al. A Mechanism To Explain the Selection of the Hepatitis e Antigen-Negative Mutant during Chronic Hepatitis B Virus Infection J. Virol., February 1, 2009; 83(3): 1379 - 1392. [Abstract] [Full Text] [PDF]

				Y. Diaz-de-Durana, G. T. Mantchev, R. J. Bram, and A. Franco TACI-BLyS signaling via B-cell-dendritic cell cooperation is required for naive CD8+ T-cell priming in vivo Blood, January 15, 2006; 107(2): 594 - 601. [Abstract] [Full Text] [PDF]

				J.-N. Billaud, D. Peterson, M. Barr, A. Chen, M. Sallberg, F. Garduno, P. Goldstein, W. McDowell, J. Hughes, J. Jones, et al. Combinatorial Approach to Hepadnavirus-Like Particle Vaccine Design J. Virol., November 1, 2005; 79(21): 13656 - 13666. [Abstract] [Full Text] [PDF]

				P. Vanlandschoot, F. Van Houtte, B. Serruys, and G. Leroux-Roels The arginine-rich carboxy-terminal domain of the hepatitis B virus core protein mediates attachment of nucleocapsids to cell-surface-expressed heparan sulfate J. Gen. Virol., January 1, 2005; 86(1): 75 - 84. [Abstract] [Full Text] [PDF]